What is MDMA?

MDMA (3,4-methylenedioxymethamphetamine) is a synthetic psychoactive drug chemically similar to methamphetamine and mescaline. It was first synthesized in 1912 by Merck pharmaceutical company and later explored for psychotherapeutic use in the 1970s-80s before being criminalized. MDMA is currently being studied in limited clinical trials for PTSD and other conditions, but remains a Schedule I/Class A controlled substance outside of research settings.

Street Names & Forms

Form	Street Names	Appearance
Powder/Crystal	Molly, Mandy (UK), MDMA powder	White to brownish crystalline powder
Pressed Pills	Ecstasy, E, X, XTC, Beans, Pressies	Colored tablets, often stamped with logos
Capsules	Molly caps, gel caps	Gelatin capsules containing powder or crystals

How MDMA Works (Mechanism of Action)

MDMA causes the release of three key neurotransmitters and blocks their reuptake:

Neurotransmitter	Effect
Serotonin	Mood elevation, empathy, emotional closeness, altered perception
Dopamine	Euphoria, increased energy, reward
Norepinephrine	Increased heart rate, blood pressure, alertness

Unlike methamphetamine (which primarily affects dopamine), MDMA’s primary effect is on serotonin release, producing its characteristic prosocial and empathogenic effects.

Routes of Administration

Route	Onset	Duration	Additional Risks
Oral (swallowed)	30-60 minutes	3-6 hours	Nausea, delayed onset (redosing risk)
Snorted	5-15 minutes	2-4 hours	Nasal damage, more intense but shorter
Injected	Seconds	2-3 hours	Needle sharing (HIV/Hepatitis), infection, overdose risk

Immediate Effects

Physical Effects:

• Increased heart rate and blood pressure
• Increased body temperature (hyperthermia)
• Jaw clenching and teeth grinding (bruxism)
• Nausea and vomiting
• Sweating and chills
• Dilated pupils
• Decreased appetite
• Muscle tension and tremors

Psychological Effects:

• Euphoria and well-being
• Increased empathy and emotional openness
• Reduced anxiety and defensiveness
• Altered sense of time
• Heightened sensory perception (touch, sound, color)
• Feelings of connection to others
• Mild hallucinatory effects (at high doses)

Immediate Risks & Dangers

Risk	Description
Hyperthermia	Dangerously high body temperature (leading cause of MDMA-related death) — can exceed 40-42°C (104-108°F)
Hyponatremia	Low blood sodium from excessive water intake (especially in women) — can cause seizures, coma, death
Serotonin Syndrome	Agitation, confusion, muscle rigidity, hyperthermia (can be fatal)
Cardiac Events	Heart attack, arrhythmia, sudden cardiac death
Psychosis	At high doses — paranoia, hallucinations, delusions

Overdose Signs & Emergency Response

Overdose Signs:

• Severe hyperthermia (body temperature > 39-40°C / 102-104°F)
• Altered mental status (confusion, agitation, delirium, unresponsiveness)
• Seizures (generalized convulsions)
• Tachycardia (heart rate > 140 bpm)
• Hypertension or hypotension
• Hyponatremia symptoms (nausea, headache, confusion, seizures, coma)
• Rhabdomyolysis (dark urine, muscle pain, weakness)

Emergency Response:

• Call 911 or local emergency services immediately
• Cool the person (remove excess clothing, apply cool wet cloths, fans, ice packs to armpits/groin)
• If unconscious, place in recovery position
• Do not force water — if hyponatremia is suspected, too much water is dangerous
• Do not give ice baths (can cause shock)
• Be prepared to provide emergency responders with information about what was taken

Long-Term Health Consequences

Consequence	Description
Cognitive impairment	Memory problems, attention deficits (may be reversible with abstinence)
Depression	Serotonin depletion after use — can persist for days to weeks
Anxiety disorders	Increased anxiety, panic attacks
Liver failure	Acute hepatitis, jaundice, liver transplant sometimes required

Tolerance, Dependence & Withdrawal

• Tolerance: Develops rapidly (effects diminish with repeated use)
• Physical dependence: Low (no classic withdrawal syndrome)
• Psychological dependence: Moderate (cravings, continued use despite harm)
• Addiction potential: Moderate

Withdrawal Symptoms (after heavy use):

• Fatigue
• Depression
• Anxiety
• Irritability
• Difficulty concentrating
• Decreased appetite
• Insomnia

Common Adulterants & Contaminants

Adulterant	Risk
Methamphetamine	Increased heart rate/strain, higher addiction risk, longer duration
Caffeine	Increased stimulant effects, jitters, dehydration
Synthetic cathinones (“bath salts”)	Severe agitation, psychosis, death
Fentanyl	High risk of fatal overdose
PMA/PMMA	Very narrow safety margin — multiple deaths reported

Drug Interactions

Drug Class	Interaction	Risk Level
MAO inhibitors	Hypertensive crisis, serotonin syndrome	Life-threatening
SSRIs (antidepressants)	Diminished MDMA effects; possible serotonin syndrome	Moderate
Other stimulants (cocaine, meth)	Excessive CNS stimulation, heart attack, seizure	High
Alcohol	Increased dehydration, poor judgment, hyponatremia	High

Legal Status (United States & International)

Jurisdiction	Classification	Penalty for Possession
United States (federal)	Schedule I	Up to 1 year imprisonment + fine
United Kingdom	Class A	Up to 7 years imprisonment + unlimited fine
Canada	Schedule I	Up to 3 years imprisonment
Australia	Schedule 9	Up to 2 years imprisonment + fine

Clinical Research (Educational Context)

MDMA is currently being studied in limited clinical trials for:

• Post-Traumatic Stress Disorder (PTSD): Phase III trials completed; not yet FDA approved as of 2025
• Social anxiety in autistic adults: Phase II trials
• Alcohol use disorder: Early research

IMPORTANT: These are clinical trials only — not approved medical use. MDMA remains a Schedule I illicit drug outside of tightly controlled research settings. Do not self-medicate.

Harm Reduction Information (Educational Only)

Recommendation	Rationale
Test your pills/powder	Fentanyl test strips, reagent tests (Marquis, Mecke, Simon’s) detect adulterants
Start with half dose	Potency varies widely; better to underdose than overdose
Wait at least 1-2 hours before redosing	Onset is slow; redosing too early causes toxicity
Limit total use to once every 1-3 months	Neurotoxicity risk increases with frequent use
Stay hydrated (not overhydrated)	1-2 glasses (250-500 mL) per hour — avoid excessive water
Cool down regularly	Take breaks from dancing; cool body with wet cloths
Do not use alone	Someone can call for help if emergency occurs

Emergency Resources

Resource	Contact	Purpose
911 / Emergency	911	Life-threatening emergency (overdose, seizure, hyperthermia)
Poison Control (US)	1-800-222-1222	Overdose guidance
SAMHSA Helpline (US)	1-800-662-4357	Substance use support, 24/7 confidential
DanceSafe (harm reduction)	dancesafe.org	Pill testing information, education
Fireside Project	6-2FIRESIDE (623-473-7433)	Support for difficult psychedelic experiences

Educational Summary

MDMA (Molly/Ecstasy) is an illegal Schedule I/Class A synthetic psychoactive drug that produces euphoria, empathy, and increased energy. It carries significant risks including fatal hyperthermia, hyponatremia, serotonin syndrome, and organ failure. Adulteration with fentanyl, methamphetamine, synthetic cathinones, or other drugs is common and increases overdose risk. There is no safe dose of illicit MDMA. Clinical trials for PTSD are ongoing, but self-medication is dangerous and illegal.

Note: This information is for educational and awareness purposes only. MDMA is a Schedule I/Class A controlled substance with no accepted medical use outside of limited clinical trials. It is illegal to possess, sell, or distribute. Nothing here is medical advice or an endorsement of use. If you or someone you know is experiencing a medical emergency, call 911 immediately. If you need help for substance use, contact SAMHSA at 1-800-662-4357.